Search

The symmetries of a crystal are notoriously uncorrelated to those of its constituent molecules. This symmetry breaking is typically thought to occur during crystallization. Here we demonstrate that one of the two symmetry elements of olanzapine crystals, an inversion centre, emerges in solute dimers extant in solution prior to crystallization. We combine time-resolved in situ scanning probe microscopy to monitor the crystal growth processes with all-atom molecular dynamics simulations. We show that crystals grow non-classically, predominantly by incorporation of centrosymmetric dimers. The growth rate of crystal layers exhibits a quadratic dependence on the solute concentration, characteristic of the second-order kinetics of the incorporation of dimers, which exist in equilibrium with a majority of monomers. We show that growth by dimers is preferred due to overwhelming accumulation of adsorbed dimers on the crystal surface, where it is complemented by dimerization and expedites dimer incorporation into growth sites. Crystal symmetry is notoriously uncorrelated to the symmetry of the constituent molecules that make up a crystal. Symmetry breaking is typically thought to occur during nucleation and growth, but a symmetry element of olanzapine crystals—an inversion centre—has now been shown to emerge in centrosymmetric dimers extant in solution prior to crystallization.

Solution crystallization is a part of the synthesis of materials ranging from geological and biological minerals to pharmaceuticals, fine chemicals, and advanced electronic components. Attempts to predict the structure, growth rates and properties of emerging crystals have been frustrated, in part, by the poor understanding of the correlations between the oligomeric state of the solute, the growth unit, and the crystal symmetry. To explore how a solute monomer or oligomer is selected as the unit that incorporates into kinks and how crystal symmetry impacts this selection, we combine scanning probe microscopy, optical spectroscopy, and all-atom molecular simulations using as examples two organic materials, olanzapine (OZPN) and etioporphyrin I (EtpI). The dominance of dimeric structures in OZPN crystals has spurred speculation that the dimers preform in the solution, where they capture the majority of the solute, and then assemble into crystals. By contrast, EtpI in crystals aligns in parallel stacks of flat EtpI monomers unrelated by point symmetry. Raman and absorption spectroscopies show that solute monomers are the majority solute species in solutions of both compounds. Surprisingly, the kinetics of incorporation of OZPN into kinks is bimolecular, indicating that the growth unit is a solute dimer, a minority solution component. The disconnection between the dominant solute species, the growth unit, and the crystal symmetry is even stronger with EtpI, for which the (010) face grows by incorporating monomers, whereas the growth unit of the (001) face is a dimer. Collectively, the crystallization kinetics results with OZPN and EtpI establish that the structures of the dominant solute species and of the incorporating solute complex do not correlate with the symmetry of the crystal lattice. In a broader context, these findings illuminate the immense complexity of crystallization scenarios that need to be explored on the road to the understanding and control of crystallization.

The structure and composition of the crystal growth unit are of huge fundamental and practical consequence. We propose a method to identify the solute species that incorporates into the growth site on crystal surfaces, the kinks, which rests on the kinetics of the elementary reaction at the kinks. We use as model crystals olanzapine, an antipsychotic medication, and etioporphyrin I, a field-effect transistor. We combine time-resolved in situ atomic force microscopy with Raman and absorption spectroscopies, complemented by density functional theory and all-atom molecular dynamics modeling of the solutions. We show that the structure of the growth unit cannot be deduced neither from the solute oligomers nor from the crystal structure. Chemical kinetics analyses reveal that if the dominant solute species is the one that incorporates into the crystal growth sites, then the kinetics of layer growth complies with a monomolecular rate law. By contrast, if the crystal growth unit assembles from two units of the dominant solute form, a bimolecular rate law ensues. Solutions of both olanzapine and etioporphyrin I are dominated by solute monomers, which exist in equilibrium with a minority of dimers. Whereas numerous olanzapine crystal structures incorporate dimer motifs, etioporphyrin I crystals organize as stacks of monomers. Olanzapine crystal grow by incorporation of dimers. One of the studied face of etioporphyrin I grows by incorporation of the majority monomers, whereas the other one selects the minority dimers as a growth unit. The results highlight the power of the crystallization kinetics analyses to identify the growth unit and illuminate one of the most challenging issues of crystal growth.